Form 4: Bio-Path Holdings CEO Acquires Options in Company Stock

Peter Nielsen, President, CEO, and CFO of Bio-Path Holdings, Inc., reports the acquisition of options to purchase 25,000 shares of common stock.

Summary

• On July 30, 2024, Peter Nielsen, the President, CEO, and CFO of Bio-Path Holdings, Inc., acquired options to purchase 25,000 shares of the company's common stock.
• The exercise price for these options is $1.55 per share.
• The options vest over a four-year period, starting with one-fourth vesting on the first anniversary of the grant date, and the remainder vesting in equal monthly increments thereafter.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of executive compensation. The acquisition of options could be seen as a positive sign of management's confidence, but it's not definitively bullish.

Positives

• The CEO's acquisition of options may signal confidence in the company's future performance.

Industry Context

Executive compensation packages often include stock options to align management's interests with those of shareholders. This Form 4 filing is a routine disclosure of such activity.

Stakeholder Impact

• The acquisition of options by the CEO could potentially align management's interests more closely with those of shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Options, Stock Options, Peter Nielsen, Bio-Path Holdings, BPTH, Executive Compensation